The Effect of HLADQB1 Alleles on Breakthrough Events During Chronic HBV Treatment with Genetically Low Barrier Drugs

dc.authorid0000-0003-1575-8642
dc.authorid0000-0002-2263-6689
dc.contributor.authorDoganay, Levent
dc.contributor.authorTuncer, İlyas
dc.contributor.authorKatrinli, Seyma
dc.contributor.authorEnc, Feruze Yilmaz
dc.contributor.authorOzturk, Oguzhan
dc.contributor.authorÇolak, Yaşar
dc.contributor.authorUlaşoğlu, Celal
dc.date.accessioned2025-05-10T19:28:29Z
dc.date.issued2012
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA
dc.description.abstract[No abstract available]
dc.description.sponsorshipAmer Assoc Study Liver Dis
dc.identifier.endpage1058A
dc.identifier.issn0270-9139
dc.identifier.scopusqualityQ1
dc.identifier.startpage1057A
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7363
dc.identifier.volume56
dc.identifier.wosWOS:000310955603450
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleThe Effect of HLADQB1 Alleles on Breakthrough Events During Chronic HBV Treatment with Genetically Low Barrier Drugs
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
7363
Boyut:
382.65 KB
Biçim:
Adobe Portable Document Format